Ventas, Inc. (VTR)
Real Estate · Health Care REITs · US stock · S&P 500 component
$85.86
▲ +1.00 (1.18%)
Day's range
$84.56 – $86.04
52-week range
$66.51 – $100.99
Red flags⚠ Heavy dilution
About Ventas, Inc.
Ventas is a real estate investment trust that owns health care properties, with senior housing communities as its core business. Its portfolio also includes medical office buildings, life science and research buildings, and hospitals, and it works with operators who run many of the communities. Tenants and residents include senior living operators, health systems, universities and research companies, and older adults who live in its communities.
Revenue comes from rent and from resident fees at senior housing communities. It was $6.4 billion over the last twelve months, with growth of 12.2% a year across the last three years. The operating margin is 13.0%, and the business earns a profit of 5% on the capital invested in it. Net debt is 0.1 times EBITDA. The dividend yield is 2.4%. On the site's X-Ray Score it receives 47 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
Price chart
52-wk range $66.51 – $100.99Volume 3,854,300Daily, split-adjusted
Vitals
Market cap$42.7B
52-week range$66.51 – $100.99
Volume (last day)3,854,300
P/E (TTM)150.2
EBIT / EV yield1.9%
Free-cash-flow yield–
Dividend yield2.4%
Revenue (TTM)$6.4B
Net income (TTM)$273M
Operating margin13.0%
Return on capital5.1%
Debt incl. leases$496M
Cash & securities$199M
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
Not rated
REIT valuation (FFO multiples + DDM) not built yet: not rated
What this means
Read the lenses below
A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Real Estate peers. Open a lens to see the numbers behind it.
Valuation
Weak
15/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield1.9%
Growth
Strong
79/100
Growing faster than most of its sector.
See the numbers →
Revenue growth (3y)12.2%
Growth consistency100%
Profitability
Weak
47/100
Earns lower returns on its capital than most peers.
See the numbers →
Return on invested capital5.1%
Operating margin13.0%
Financial health
Fair
66/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score8 / 9
Net debt / EBITDA0.1×
Interest cover1.3×
Dividends
Weak
27/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield2.4%
Dividend growth6.1%
Quarterly results: last 6 quarters
+13.2%
Mar '25
+18.3%
Jun '25
+20.4%
Sep '25
+21.7%
Dec '25
+22.0%
Mar '26
+21.7%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $1.7B, diluted EPS $0.14.
Compare with peers
WELL Welltower Inc.47 DOC Healthpeak Properties,...37Other Health Care REITs companies by X-Ray Score.
Fundamentals checklist
● 5 Good · ● 0 Average · ● 4 BadCash quality
Earnings backed by cashGood
Risk models
Piotroski F-ScoreGood
Growth
Revenue growth (3y)Good
Growth consistencyGood
Balance sheet
Net debt / EBITDAGood
Interest coverBad
Valuation
EBIT / EV yieldBad
Profitability
Return on invested capitalBad
Operating marginBad
Each check is graded against the company's sector, not a fixed number. Checklist score 49/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $3.8B | $4.1B | $4.5B | $4.9B | $5.8B |
| Operating income | $278M | $373M | $459M | $595M | $817M |
| Net income | $57M | −$41M | −$30M | $88M | $262M |
| Operating cash flow | $1.0B | $1.1B | $1.1B | $1.3B | $1.6B |
| Operating margin | 7.3% | 9.0% | 10.2% | 12.1% | 14.0% |
| Free cash flow | −$776M | $219M | $470M | −$1.2B | −$1.3B |
| Diluted EPS | $0.13 | $-0.12 | $-0.10 | $0.19 | $0.54 |
Fiscal years, from SEC filings.
Technical summary
Daily
Neutral
7 bullish · 2 neutral · 7 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
| SMA 10 | 82.95 | Bullish |
| EMA 10 | 84.09 | Bullish |
| SMA 20 | 84.33 | Bullish |
| EMA 20 | 84.71 | Bullish |
| SMA 50 | 87.93 | Bearish |
| EMA 50 | 86.80 | Bearish |
| SMA 100 | 88.23 | Bearish |
| EMA 100 | 87.08 | Bearish |
| SMA 200 | 85.16 | Bullish |
| EMA 200 | 84.23 | Bullish |
Oscillators (daily)
| RSI (14) | 52.39 | Neutral |
| MACD (12, 26) | -1.14 | Bearish |
| Momentum (12) | 0.99 | Bullish |
| Stochastic %K (14) | 81.55 | Bearish |
| Williams %R (14) | -18.45 | Bearish |
| CCI (20) | 42.80 | Neutral |
Pivot points (classic, last session)
S3 83.45 | S2 84.01 | S1 84.93 | Pivot 85.49 | R1 86.41 | R2 86.97 | R3 87.89 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.04 USD
Yield on today's price
2.38%
Frequency
Quarterly
Next ex-dividend date
Not announced
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | 0.5200 |
| 30 Jun 2026 | 0.5200 |
| 31 Mar 2026 | 0.5200 |
| 31 Dec 2025 | 0.4800 |
| 30 Sep 2025 | 0.4800 |
| 30 Jun 2025 | 0.4800 |
| 31 Mar 2025 | 0.4800 |
| 31 Dec 2024 | 0.4500 |
| 1 Oct 2024 | 0.4500 |
| 1 Jul 2024 | 0.4500 |
| 28 Mar 2024 | 0.4500 |
| 29 Dec 2023 | 0.4500 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
VTR SEC filings
15 Sep 2026
8-KSEC EDGAR
Director or officer change
30 Jul 2026
10-QSEC EDGAR
Quarterly report
29 Jul 2026
8-KSEC EDGAR
Results of operations
15 Jun 2026
8-KSEC EDGAR
Director or officer change; Other events
15 May 2026
8-KSEC EDGAR
Director or officer change; Shareholder vote results
15 May 2026
424B5SEC EDGAR
424B5
28 Apr 2026
10-QSEC EDGAR
Quarterly report
27 Apr 2026
8-KSEC EDGAR
Results of operations
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.